Prospector Partners’s Haemonetics HAE Stock Holding History

Prospector Partners’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-87,405	Closed	-$10.4M	–	116
2020 Q4	$10.4M	Buy	87,405 +2,500	+3%	+$269K	1.29%	29
2020 Q3	$7.41M	Buy	+84,905	New	+$7.42M	1.11%	35
2018 Q2	–	Sell	-34,500	Closed	-$2.52M	–	130
2018 Q1	$2.52M	Sell	34,500 -8,200	-19%	-$563K	0.37%	79
2017 Q4	$2.48M	Sell	42,700 -7,600	-15%	-$400K	0.36%	81
2017 Q3	$2.26M	Hold	50,300	–	–	0.34%	79
2017 Q2	$1.99M	Hold	50,300	–	–	0.31%	83
2017 Q1	$2.04M	Hold	50,300	–	–	0.31%	85
2016 Q4	$2.02M	Hold	50,300	–	–	0.3%	89
2016 Q3	$1.82M	Hold	50,300	–	–	0.29%	95
2016 Q2	$1.46M	Hold	50,300	–	–	0.25%	98
2016 Q1	$1.76M	Hold	50,300	–	–	0.3%	91
2015 Q4	$1.62M	Hold	50,300	–	–	0.29%	92
2015 Q3	$1.63M	Hold	50,300	–	–	0.23%	99
2015 Q2	$2.08M	Sell	50,300 -4,200	-8%	-$177K	0.25%	92
2015 Q1	$2.45M	Hold	54,500	–	–	0.18%	114
2014 Q4	$2.04M	Sell	54,500 -40,100	-42%	-$1.47M	0.15%	123
2014 Q3	$3.3M	Hold	94,600	–	–	0.18%	120
2014 Q2	$3.34M	Hold	94,600	–	–	0.16%	123
2014 Q1	$3.08M	Buy	94,600 +80,400	+566%	+$3.07M	0.15%	137
2013 Q4	$598K	Hold	14,200	–	–	0.03%	182
2013 Q3	$566K	Hold	14,200	–	–	0.03%	188
2013 Q2	$587K	Buy	+14,200	New	+$575K	0.03%	178

Other funds holding HAE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prospector Partners's HAE Position: Q1 2021 in Review

Prospector Partners sold out of Haemonetics (HAE) in Q1 2021, closing a stake of 87,405 shares — an estimated $10.4M sold.

Prospector Partners first reported a position in HAE in Q2 2013 and held it in 22 quarters. The position peaked at $10.4M in Q4 2020. 296 funds tracked by Wall St. Rank hold HAE as of Q1 2021.

Prospector Partners reported no remaining Haemonetics position as of Q1 2021 after selling out during the quarter.
Prospector Partners sold 87,405 Haemonetics shares in Q1 2021, an estimated $10.4M.
Prospector Partners first reported a position in Haemonetics in Q2 2013 and held it in 22 quarters.
Prospector Partners's Haemonetics position peaked at $10.4M in Q4 2020.
296 funds tracked by Wall St. Rank held Haemonetics as of Q1 2021.

Based on Prospector Partners's 13F filing for Q1 2021, filed 13 May 2021.